TNFα induced FOXP3-NFκB interaction dampens the tumor suppressor role of FOXP3 in gastric cancer cells

Biochemical and Biophysical Research Communications

Volumn 430, Issue 1, 2013, Pages 436-441

  Hao, Qiang ^a   Li, Weina ^a   Zhang, Cun ^a   Qin, Xin ^a   Xue, Xiaochang ^a   Li, Meng ^a   Shu, Zhen ^a   Xu, Tianjiao ^a   Xu, Yujin ^a   Wang, Weihua ^a   Zhang, Wei ^a   Zhang, Yingqi ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Foxp3; Gastric cancer; Inflammation; NF B; P21; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P21; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; PRIORITY JOURNAL; STOMACH CANCER; UPREGULATION;

CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INFLAMMATION; STOMACH NEOPLASMS; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS; UP-REGULATION;

EID: 84872390286     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.039     Document Type: Article

References (24)

1. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance. regulatory T cell development and the forkhead family transcription factor. Foxp3. Nat. Immunol. 2005, 6:331-337.
2. Sakaguchi S. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 2005, 6:345-352.
3. Zuo T., Wang L., Morrison C., Chang X., Zhang H., Li W., Liu Y., Wang Y., Liu X., Chan M.W., Liu J.Q., Love R., Liu C.G., Godfrey V., Shen R., Huang T.H., Yang T., Park B.K., Wang C.Y., Zheng P. FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of the HER-2/ErbB2 oncogene. Cell 2007, 129:1275-1286.
4. Zuo T., Liu R., Zhang H., Chang X., Liu Y., Wang L., Zheng P. FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2. J. Clin. Invest. 2007, 117:3765-3773.
5. Liu R., Wang L., Chen G., Katoh H., Chen C., Liu Y., Zheng P. FOXP3 up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus. Cancer Res. 2009, 69:2252-2259.
6. Zhang H.Y., Sun H. Up-regulation of Foxp3 inhibits cell proliferation, migration and invasion in epithelial ovarian cancer. Cancer Lett. 2010, 287:91-97.
7. Wang L.H., Su L., Wang J.T. Correlation between elevated FOXP3 expression and increased lymph node metastasis of gastric cancer. Chin. Med. J. (Engl.) 2010, 123:3545-3549.
8. Terzic J., Grivennikov S., Karin E., Karin M. Inflammation and colon cancer. Gastroenterology 2010, 138:2101-2114 e2105.
9. Im H., Grass J.A., Johnson K.D., Boyer M.E., Wu J., Bresnick E.H. Measurement of protein-DNA interactions in vivo by chromatin immunoprecipitation. Methods Mol. Biol. 2004, 284:129-146.
10. Karanikas V., Speletas M., Zamanakou M., Kalala F., Loules G., Kerenidi T., Barda A.K., Gourgoulianis K.I., Germenis A.E. Foxp3 expression in human cancer cells. J. Transl. Med. 2008, 6:19.
11. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
12. Rayburn E.R., Ezell S.J., Zhang R. Anti-inflammatory agents for cancer therapy. Mol. Cell Pharmacol. 2009, 1:29-43.
13. Sarkar D., Fisher P.B. Molecular mechanisms of aging-associated inflammation. Cancer Lett. 2006, 236:13-23.
14. Loizou L., Andersen K.G., Betz A.G. Foxp3 interacts with c-Rel to mediate NF-kappaB repression. PLoS One 2011, 6:e18670.
15. Gao Y., Lin F., Su J., Gao Z., Li Y., Yang J., Deng Z., Liu B., Tsun A., Li B. Molecular mechanisms underlying the regulation and functional plasticity of FOXP3(+) regulatory T cells. Genes Immun. 2012, 13:1-13.
16. Xu X., Prorock C., Ishikawa H., Maldonado E., Ito Y., Gelinas C. Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. Mol. Cell Biol. 1993, 13:6733-6741.
17. Schmitz M.L., Stelzer G., Altmann H., Meisterernst M., Baeuerle P.A. Interaction of the COOH-terminal transactivation domain of p65 NF-kappaB with TATA-binding protein, transcription factor IIB, and coactivators. J. Biol. Chem. 1995, 270:7219-7226.
18. Farmer G., Colgan J., Nakatani Y., Manley J.L., Prives C. Functional interaction between p53, the TATA-binding protein (TBP), andTBP-associated factors in vivo. Mol. Cell Biol. 1996, 16:4295-4304.
19. Schaeffer V., Janody F., Loss C., Desplan C., Wimmer E.A. Bicoid functions without its TATA-binding protein-associated factor interaction domains. Proc. Natl. Acad. Sci. USA 1999, 96:4461-4466.
20. Quinn P.G. Mechanisms of basal and kinase-inducible transcription activation by CREB. Prog. Nucl. Acid Res. Mol. Biol. 2002, 72:269-305.
21. Zhang W., Kadam S., Emerson B.M., Bieker J.J. Site-specific acetylation by p300 or CREB binding protein regulates erythroid Kruppel-like factor transcriptional activity via its interaction with the SWI-SNF complex. Mol. Cell Biol. 2001, 21:2413-2422.
22. Li B., Samanta A., Song X., Furuuchi K., Iacono K.T., Kennedy S., Katsumata M., Saouaf S.J., Greene M.I. FOXP3 ensembles in T-cell regulation. Immunol. Rev. 2006, 212:99-113.
23. Van Mierlo G.J., Scherer H.U., Hameetman M., Morgan M.E., Flierman R., Huizinga T.W., Toes R.E. Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators. J. Immunol. 2008, 180:2747-2751.
24. Kraaij M.D., Savage N.D., Van der Kooij S.W., Koekkoek K., Wang J., Van den Berg J.M., Ottenhoff T.H., Kuijpers T.W., Holmdahl R., Van Kooten C., Gelderman K.A. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc. Natl. Acad. Sci. USA 2010, 107:17686-17691.